… These observations lead us to conclude that despite the wide heterogeneity, there is …
responses. This is likely to lead to the wide clinical, pathological, and immunological heterogeneity …

… Such “response heterogeneity” is considered pervasive among all groups of individuals (eg, …
This article presents an argument that researchers should examine response heterogeneity …

… The heterogeneity in the pathology of MS could form the basis of both the polygenic nature
… heterogeneity of the disease with respect to clinical presentation and response to therapy. …

… heterogeneity in the responses of resident cells in the brain and spinal cord. It remains to
be determined whether these findings translate to humans and/or whether there are other …

… among baseline characteristics, telerehabilitation and response heterogeneity. We discuss
how research on examining response heterogeneity may be advanced by conducting mega-…

… The mechanisms underlying heterogeneity in the treatment response are not completely
understood, although genetic factors probably have an important role. Given the complex …

… Disease course and treatment response heterogeneity. Greater post-rehabilitation …
These differences and response heterogeneity between the PMS and RRMS participants …

… to be heterogeneous. This heterogeneity may also extend to therapeutic responses and
adverse effects and can be accounted for by multiple factors including genetic differences, as …

… MS, we studied their link with features of disease heterogeneity. We identified patients with
different CSF-infiltrating CD4 + T-cell responses against myelin and GDP-L-FS peptides and …

… IFN-β response. Relapsing-remitting multiple sclerosis (RRMS) is a heterogeneous disease
that … There is a wide variation in treatment response to therapies including interferon (IFN)–β. …